US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 13.780
  • +0.060+0.44%
Trading Nov 25 12:02 ET
1.39BMarket Cap-14206P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
93.76M
8.19M
0
0
0
0
0
0
0
0
Operating revenue
--93.76M
--8.19M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
1.59M
707K
0
0
Gross profit
92.17M
7.49M
0
0
Operating expense
21.57%62.54M
148.29%122.29M
45.60%66.77M
40.27%206.06M
39.24%59.52M
29.57%51.44M
34.14%49.25M
65.26%45.86M
101.96%146.91M
94.51%42.74M
Selling and administrative expenses
58.53%28.97M
76.82%30.19M
47.32%26.56M
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
110.20%61.29M
55.04%16.72M
-General and administrative expense
----
----
47.32%26.56M
23.25%75.54M
----
----
----
41.44%18.03M
110.20%61.29M
55.04%16.72M
Research and development costs
1.21%33.56M
186.20%92.11M
44.49%40.21M
52.45%130.52M
43.54%37.35M
50.50%33.16M
42.65%32.18M
85.48%27.83M
96.44%85.62M
132.55%26.02M
Operating profit
157.61%29.64M
-133.09%-114.81M
-45.60%-66.77M
-40.27%-206.06M
-39.24%-59.52M
-29.57%-51.44M
-34.14%-49.25M
-65.26%-45.86M
-101.96%-146.91M
-94.51%-42.74M
Net non-operating interest income expense
Other net income (expense)
23.28%6.52M
3,201.45%111.95M
25.79%4.36M
262.67%17.15M
90.05%5.01M
177.73%5.29M
1,694.18%3.39M
346,100.00%3.46M
43,081.82%4.73M
14,533.33%2.63M
Gain on sale of security
0.59%5.32M
16.32%3.96M
25.94%4.37M
262.14%17.19M
88.87%5.02M
179.21%5.29M
1,702.12%3.41M
173,200.00%3.47M
118,550.00%4.75M
--2.66M
Other non- operating income (expenses)
40,000.00%1.2M
720,033.33%107.99M
-150.00%-10K
-122.22%-40K
30.77%-18K
-133.33%-3K
---15K
-300.00%-4K
-20.00%-18K
-285.71%-26K
Income before tax
178.34%36.16M
93.77%-2.86M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
Income tax
-882K
1.55M
0
0
Net income
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
Net income continuous Operations
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
Minority interest income
0
0
Net income attributable to the parent company
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-101.26%-142.18M
-82.83%-40.11M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
16.68%-142.18M
-82.83%-40.11M
Basic earnings per share
170.37%0.38
91.80%-0.05
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
Diluted earnings per share
170.37%0.38
91.80%-0.05
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 93.76M8.19M00000000
Operating revenue --93.76M--8.19M--0--0--0--0--0--0--0--0
Cost of revenue 1.59M707K00
Gross profit 92.17M7.49M00
Operating expense 21.57%62.54M148.29%122.29M45.60%66.77M40.27%206.06M39.24%59.52M29.57%51.44M34.14%49.25M65.26%45.86M101.96%146.91M94.51%42.74M
Selling and administrative expenses 58.53%28.97M76.82%30.19M47.32%26.56M23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M110.20%61.29M55.04%16.72M
-General and administrative expense --------47.32%26.56M23.25%75.54M------------41.44%18.03M110.20%61.29M55.04%16.72M
Research and development costs 1.21%33.56M186.20%92.11M44.49%40.21M52.45%130.52M43.54%37.35M50.50%33.16M42.65%32.18M85.48%27.83M96.44%85.62M132.55%26.02M
Operating profit 157.61%29.64M-133.09%-114.81M-45.60%-66.77M-40.27%-206.06M-39.24%-59.52M-29.57%-51.44M-34.14%-49.25M-65.26%-45.86M-101.96%-146.91M-94.51%-42.74M
Net non-operating interest income expense
Other net income (expense) 23.28%6.52M3,201.45%111.95M25.79%4.36M262.67%17.15M90.05%5.01M177.73%5.29M1,694.18%3.39M346,100.00%3.46M43,081.82%4.73M14,533.33%2.63M
Gain on sale of security 0.59%5.32M16.32%3.96M25.94%4.37M262.14%17.19M88.87%5.02M179.21%5.29M1,702.12%3.41M173,200.00%3.47M118,550.00%4.75M--2.66M
Other non- operating income (expenses) 40,000.00%1.2M720,033.33%107.99M-150.00%-10K-122.22%-40K30.77%-18K-133.33%-3K---15K-300.00%-4K-20.00%-18K-285.71%-26K
Income before tax 178.34%36.16M93.77%-2.86M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M
Income tax -882K1.55M00
Net income 180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M
Net income continuous Operations 180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M
Minority interest income 00
Net income attributable to the parent company 180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-101.26%-142.18M-82.83%-40.11M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders 180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M16.68%-142.18M-82.83%-40.11M
Basic earnings per share 170.37%0.3891.80%-0.05-22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56
Diluted earnings per share 170.37%0.3891.80%-0.05-22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data